Filtered By:
Condition: Hemorrhagic Stroke
Procedure: Angioplasty
Countries: USA Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 6 results found since Jan 2013.

E-006 Carotid artery revascularization using the walrus balloon guide catheter: safety and feasibility from a US multicenter experience
ConclusionWalrus BGC for proximal flow-control is safe and effective during eCAS and tCAS. Procedural success was achieved in all cases, with favorable safety and functional outcomes on short term follow-up.Disclosures M. Salem: None. S. Kvint: None. A. Baig: None. A. Monteiro: None. G. Cortez: None. A. Luisa Kuhn: None. O. Goren: None. S. Dalal: None. B. Jankowitz: None. O. Choudhri: None. D. Raper: None. O. Tanweer: None. P. Jabbour: None. R. Starke: None. E. Levy: None. C. Griessenauer: None. A. Puri: None. R. Hanel: None. A. Siddiqui: None. J. Burkhardt: None.
Source: Journal of NeuroInterventional Surgery - July 23, 2022 Category: Neurosurgery Authors: Salem, M., Kvint, S., Baig, A., Monteiro, A., Cortez, G., Luisa Kuhn, A., Goren, O., Dalal, S., Jankowitz, B., Choudhri, O., Raper, D., Tanweer, O., Jabbour, P., Starke, R., Levy, E., Griessenauer, C., Puri, A., Hanel, R., Siddiqui, A., Burkhardt, J. Tags: SNIS 19th annual meeting electronic poster abstracts Source Type: research

O-052 The pennsylvania post-market multicenter experience with flow re-direction endoluminal device (FRED)
ConclusionThe results of the early post-market experience with the FRED device show reasonable safety and adequate aneurysmal occlusion rates comparable to other flow diverters. However, more extensive multicenter studies with more extended follow-up data are needed to assess the long-term safety and durability of the device.Abstract O-052 Table 1Baseline descriptive statistics Number of patients n=61 Gender Male 11 (18%) Female 50 (82%) Age (Years: median; IQR) 58 (51 – 68) Multiple Intracranial Aneurysms 21 (34.4%) Family history of aneurysms 9 (14.8%) Smoking History Never smokers 26 (42.6%) Past smokers 13 (21.3...
Source: Journal of NeuroInterventional Surgery - July 23, 2022 Category: Neurosurgery Authors: Salem, M., Kvint, S., Hendrix, P., Al Saiegh, F., Gajjar, A., Goren, O., Gross, B., Jabbour, P., Lang, M., Schirmer, C., Tjoumakaris, S., Griessenauer, C., Burkhardt, J. Tags: SNIS 19th annual meeting oral abstracts Source Type: research

Refractory Stroke Thrombectomy: Prevalence, Etiology, and Adjunctive Treatment in a North American Cohort INTERVENTIONAL
CONCLUSIONS: Refractory stroke thrombectomy is encountered in <10% of cases, independently associated with diabetes, and related to underlying vessel wall pathology (intracranial atherosclerotic disease and/or intracranial arterial dissection) or, less commonly, recalcitrant emboli. Emergent salvage interventions with glycoprotein IIb/IIIa inhibitors or intracranial angioplasty and/or stenting are safe and effective adjunctive treatments.
Source: American Journal of Neuroradiology - July 13, 2021 Category: Radiology Authors: Abdalla, R. N., Cantrell, D. R., Shaibani, A., Hurley, M. C., Jahromi, B. S., Potts, M. B., Ansari, S. A. Tags: INTERVENTIONAL Source Type: research

Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation
In conclusion, the present study identified canagliflozin as a potent inhibitor of human EC proliferation. The anti-proliferative action of canagliflozin is observed in ECs isolated from both the venous and arterial circulation, and is partly due to the blockade of cyclin A expression. In addition, this study found that canagliflozin inhibits tube formation in cultured ECs and mouse aortic rings. Notably, these actions are specific for canagliflozin and not seen with other SGLT2 inhibitors. The ability of canagliflozin to exert these pleiotropic effects on EC function may contribute to both the adverse and salutary actions...
Source: Frontiers in Pharmacology - April 15, 2019 Category: Drugs & Pharmacology Source Type: research

Angiographical Identification of Intracranial, Atherosclerosis-Related, Large Vessel Occlusion in Endovascular Treatment
Conclusions Among only a few identification methods, the ICAS-LVO can be feasibly identified by angiographical findings. The identification of ICAS-LVO based on based on occlusion type, is a reliable and practical identification method for ICAS-LVO. Procedural details by occlusion type and its predictability to endovascular results were reported. Furthermore, occlusion type can be determined before or in the early stages of the procedure, which may be most helpful in setting up an optimal endovascular treatment strategy. Author Contributions J-HB established the study idea, designed the manuscript structure, acquired an...
Source: Frontiers in Neurology - April 15, 2019 Category: Neurology Source Type: research

NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
CONCLUSIONS: We found no early benefit of PostC on infarct size, MSI and LV function compared to routine PCI. However, PostC was associated with improved LV remodeling at one year of follow-up, especially in subjects with MVO. PMID: 30602360 [PubMed - as supplied by publisher]
Source: Circulation Research - January 3, 2019 Category: Cardiology Authors: Traverse JH, Swingen C, Henry TD, Fox J, Wang Y, Chavez IJ, Lips DL, Lesser JR, Pedersen WR, Burke NM, Pai A, Lindberg JL, Garberich R Tags: Circ Res Source Type: research